ReP USP - Resultado da busca

Artigo de periodico
Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients (2015)
Leal, Mariana Ferreira; Calcagno, Danielle Queiroz; Chung, Janete; Freitas, Vanessa Morais ; Demachki, Samia; Assumpção, Paulo Pimentel; Chammas, Roger; Burbano, Rommel Rodríguez; Smith, Marília Cardoso
Source: Clinical and Experimental Medicine. Unidades: FM, ICB
Subjects: NEOPLASIAS DO SISTEMA DIGESTÓRIO, METÁSTASE NEOPLÁSICA (FISIOPATOLOGIA), EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Mariana Ferreira et al. Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients. Clinical and Experimental Medicine, v. 15, n. 3, p. 415-420, 2015Tradução . . Disponível em: https://doi.org/10.1007/s10238-014-0299-0. Acesso em: 05 nov. 2024.
APA
Leal, M. F., Calcagno, D. Q., Chung, J., Freitas, V. M., Demachki, S., Assumpção, P. P., et al. (2015). Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients. Clinical and Experimental Medicine, 15( 3), 415-420. doi:10.1007/s10238-014-0299-0
NLM
Leal MF, Calcagno DQ, Chung J, Freitas VM, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MC. Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients [Internet]. Clinical and Experimental Medicine. 2015 ; 15( 3): 415-420.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s10238-014-0299-0
Vancouver
Leal MF, Calcagno DQ, Chung J, Freitas VM, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MC. Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients [Internet]. Clinical and Experimental Medicine. 2015 ; 15( 3): 415-420.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s10238-014-0299-0
Artigo de periodico
Prohibitin Expression Deregulation in Gastric Cancer Is Associated with the 3′ Untranslated Region 1630 C>T Polymorphism and Copy Number Variation (2014)
Leal, Mariana Ferreira; Cirilo, Priscila Daniele Ramos; Mazzotti, Tatiane Katsue Furuya; Calcagno, Danielle Queiroz; Wisnieski, Fernanda; Demachki, Samia; Martinez, Margarita Cortes; Assumpção, Paulo Pimentel; Chammas, Roger; Burbano, Rommel Rodríguez; Smith, Marília Cardoso
Source: PLOS ONE. Unidade: FM
Subjects: REAÇÃO EM CADEIA POR POLIMERASE, EXPRESSÃO GÊNICA, POLIMORFISMO, NEOPLASIAS GÁSTRICAS (EPIDEMIOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Mariana Ferreira et al. Prohibitin Expression Deregulation in Gastric Cancer Is Associated with the 3′ Untranslated Region 1630 C>T Polymorphism and Copy Number Variation. PLOS ONE, v. 9, n. 5, p. 9 art. e98583, 2014Tradução . . Disponível em: http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0098583&representation=PDF. Acesso em: 05 nov. 2024.
APA
Leal, M. F., Cirilo, P. D. R., Mazzotti, T. K. F., Calcagno, D. Q., Wisnieski, F., Demachki, S., et al. (2014). Prohibitin Expression Deregulation in Gastric Cancer Is Associated with the 3′ Untranslated Region 1630 C>T Polymorphism and Copy Number Variation. PLOS ONE, 9( 5), 9 art. e98583. doi:10.1371/journal.pone.0098583
NLM
Leal MF, Cirilo PDR, Mazzotti TKF, Calcagno DQ, Wisnieski F, Demachki S, Martinez MC, Assumpção PP, Chammas R, Burbano RR, Smith MC. Prohibitin Expression Deregulation in Gastric Cancer Is Associated with the 3′ Untranslated Region 1630 C>T Polymorphism and Copy Number Variation [Internet]. PLOS ONE. 2014 ; 9( 5): 9 art. e98583.[citado 2024 nov. 05 ] Available from: http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0098583&representation=PDF
Vancouver
Leal MF, Cirilo PDR, Mazzotti TKF, Calcagno DQ, Wisnieski F, Demachki S, Martinez MC, Assumpção PP, Chammas R, Burbano RR, Smith MC. Prohibitin Expression Deregulation in Gastric Cancer Is Associated with the 3′ Untranslated Region 1630 C>T Polymorphism and Copy Number Variation [Internet]. PLOS ONE. 2014 ; 9( 5): 9 art. e98583.[citado 2024 nov. 05 ] Available from: http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0098583&representation=PDF
Artigo de periodico
Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications (2014)
Leal, Mariana Ferreira; Mazzotti, Tatiane Katsue Furuya; Calcagno, Danielle Queiroz; Cirilo, Priscila Daniele Ramos; Martinez, Margarita Cortes; Demachki, Samia; Assumpção, Paulo Pimentel; Chammas, Roger; Burbano, Rommel Rodríguez; Smith, Marília Cardoso
Source: BMC Gastroenterology. Unidade: FM
Subjects: NÚCLEO CELULAR, METÁSTASE NEOPLÁSICA, EXPRESSÃO GÊNICA, NEOPLASIAS GÁSTRICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Mariana Ferreira et al. Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications. BMC Gastroenterology, v. 19, n. 9, p. 10 , 2014Tradução . . Disponível em: http://www.biomedcentral.com/1471-230X/14/9. Acesso em: 05 nov. 2024.
APA
Leal, M. F., Mazzotti, T. K. F., Calcagno, D. Q., Cirilo, P. D. R., Martinez, M. C., Demachki, S., et al. (2014). Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications. BMC Gastroenterology, 19( 9), 10 . doi:10.1186/1471-230X-14-9
NLM
Leal MF, Mazzotti TKF, Calcagno DQ, Cirilo PDR, Martinez MC, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MC. Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications [Internet]. BMC Gastroenterology. 2014 ; 19( 9): 10 .[citado 2024 nov. 05 ] Available from: http://www.biomedcentral.com/1471-230X/14/9
Vancouver
Leal MF, Mazzotti TKF, Calcagno DQ, Cirilo PDR, Martinez MC, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith MC. Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications [Internet]. BMC Gastroenterology. 2014 ; 19( 9): 10 .[citado 2024 nov. 05 ] Available from: http://www.biomedcentral.com/1471-230X/14/9
Artigo de periodico
Clinical implication of 14-3-3 epsilon expression in gastric cancer (2012)
Leal, Mariana Ferreira; Calcagno, Danielle Queiroz; Demachki, Sâmia; Assumpção, Paulo Pimentel; Chammas, Roger; Burbano, Rommel Rodríguez; Smith, Marília de Arruda Cardoso
Source: World Journal of Gastroenterology. Unidade: FM
Subjects: NEOPLASIAS GÁSTRICAS (GENÉTICA;IMUNOLOGIA), WESTERN BLOTTING, EXPRESSÃO GÊNICA, PROTEÍNAS PROTO-ONCOGÊNICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Mariana Ferreira et al. Clinical implication of 14-3-3 epsilon expression in gastric cancer. World Journal of Gastroenterology, v. 18, n. 13, p. 1531-1537, 2012Tradução . . Disponível em: https://doi.org/10.3748/wjg.v18.i13.1531. Acesso em: 05 nov. 2024.
APA
Leal, M. F., Calcagno, D. Q., Demachki, S., Assumpção, P. P., Chammas, R., Burbano, R. R., & Smith, M. de A. C. (2012). Clinical implication of 14-3-3 epsilon expression in gastric cancer. World Journal of Gastroenterology, 18( 13), 1531-1537. doi:10.3748/wjg.v18.i13.1531
NLM
Leal MF, Calcagno DQ, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith M de AC. Clinical implication of 14-3-3 epsilon expression in gastric cancer [Internet]. World Journal of Gastroenterology. 2012 ; 18( 13): 1531-1537.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3748/wjg.v18.i13.1531
Vancouver
Leal MF, Calcagno DQ, Demachki S, Assumpção PP, Chammas R, Burbano RR, Smith M de AC. Clinical implication of 14-3-3 epsilon expression in gastric cancer [Internet]. World Journal of Gastroenterology. 2012 ; 18( 13): 1531-1537.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3748/wjg.v18.i13.1531

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em